Elagolix

Pelvic, Dysmenorrhea Pain Sustained Relief With Elagolix

Pelvic, Dysmenorrhea Pain Sustained Relief With Elagolix

By

Treatment with elagolix was associated with sustained reduction in average monthly dysmenorrhea and non-menstrual pelvic pain through a 12-month treatment period.

Elagolix May Be Effective for Reducing Pain From Endometriosis

Elagolix May Be Effective for Reducing Pain From Endometriosis

By

At 3 months, significantly more women receiving both doses of elagolix had reductions in dysmenorrhea and nonmenstrual pelvic pain compared with those receiving placebo.

Sign Up for Free e-Newsletters